These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 26459323)
1. Serum IL8 and mRNA level of CD11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease. Zou J; Chen J; Yan Q; Guo Q; Bao C Clin Rheumatol; 2016 Jan; 35(1):117-25. PubMed ID: 26459323 [TBL] [Abstract][Full Text] [Related]
2. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease. Ye Y; Fu Q; Wang R; Guo Q; Bao C J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087 [TBL] [Abstract][Full Text] [Related]
3. HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients. Zou J; Guo Q; Chi J; Wu H; Bao C Clin Rheumatol; 2015 Apr; 34(4):707-14. PubMed ID: 25609178 [TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease. Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease. Sun WC; Sun YC; Lin H; Yan B; Shi GX Br J Dermatol; 2012 Dec; 167(6):1236-44. PubMed ID: 23013528 [TBL] [Abstract][Full Text] [Related]
6. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240 [TBL] [Abstract][Full Text] [Related]
8. HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Oga T; Chin K; Nagai S; Mimori T; Mishima M Respir Med; 2011 Sep; 105(9):1380-7. PubMed ID: 21632230 [TBL] [Abstract][Full Text] [Related]
9. Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis. Zhu D; Qiao J; Tang S; Pan Y; Li S; Yang C; Fang H Rheumatology (Oxford); 2021 Aug; 60(8):3896-3903. PubMed ID: 33398346 [TBL] [Abstract][Full Text] [Related]
10. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases. Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528 [TBL] [Abstract][Full Text] [Related]
11. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis. Takada T; Aoki A; Asakawa K; Sakagami T; Moriyama H; Narita I; Sato S Respir Med; 2015 Sep; 109(9):1174-80. PubMed ID: 26187000 [TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients. Sun Y; Liu Y; Yan B; Shi G Rheumatol Int; 2013 May; 33(5):1295-302. PubMed ID: 23143553 [TBL] [Abstract][Full Text] [Related]
13. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis. Chen M; Quan C; Diao L; Xue F; Xue K; Wang B; Li X; Zhu X; Zheng J; Cao H Br J Dermatol; 2018 Dec; 179(6):1334-1341. PubMed ID: 30101523 [TBL] [Abstract][Full Text] [Related]
14. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858 [TBL] [Abstract][Full Text] [Related]
15. Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases. Kawasumi H; Katsumata Y; Nishino A; Hirahara S; Kawaguchi Y; Kuwana M; Yamanaka H J Rheumatol; 2018 Jul; 45(7):947-955. PubMed ID: 29657141 [TBL] [Abstract][Full Text] [Related]
16. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD. Horiike Y; Suzuki Y; Fujisawa T; Yasui H; Karayama M; Hozumi H; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Ogawa N; Suda T Rheumatology (Oxford); 2019 Dec; 58(12):2143-2152. PubMed ID: 31143953 [TBL] [Abstract][Full Text] [Related]
17. Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Sato S; Kuwana M; Fujita T; Suzuki Y Mod Rheumatol; 2013 May; 23(3):496-502. PubMed ID: 22644102 [TBL] [Abstract][Full Text] [Related]
18. Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Nara M; Komatsuda A; Omokawa A; Togashi M; Okuyama S; Sawada K; Wakui H Mod Rheumatol; 2014 Jul; 24(4):633-6. PubMed ID: 24252021 [TBL] [Abstract][Full Text] [Related]
19. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Sato S; Hoshino K; Satoh T; Fujita T; Kawakami Y; Fujita T; Kuwana M Arthritis Rheum; 2009 Jul; 60(7):2193-200. PubMed ID: 19565506 [TBL] [Abstract][Full Text] [Related]